Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. International Journal of Endocrinology and Metabolism
  4. Articles

  5. An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma
  6. Crossref

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Home
Current IssueAll IssuesIn PressSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Crossref


1. Retracted: MicroRNA‐520a‐3p suppresses epithelial–mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1‐mediated JAK/STAT signaling pathway

- Chang‐Long Bi

- Ying‐Qi Zhang

- Bo Li

- Min Guo

- Yi‐Li Fu

2. Abnormal number cell division of human thyroid anaplastic carcinoma cell line, SW 1736

- Keiichi Ikeda

- Toshiaki Tachibana

- Yuta Suzuki

- Kouki Fujioka

- Hiroshi Takeyama

- Yoshinobu Manome

3. A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database

- Mingjun Wang

- Rongjing Li

- Xiuhe Zou

- Tao Wei

- Rixiang Gong

- Jingqiang Zhu

- Zhihui Li

HomeInstructionsAPC

Articles

  • Current Issue
  • All Issues
  • In Press
  • Search

About Journal

  • Journal Information
  • Boards and Committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.